Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TGFBR1 antibody (AA 157-244)

TGFBR1 Reactivity: Human WB, ELISA, IHC, IF Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7171957
  • Target See all TGFBR1 Antibodies
    TGFBR1 (Transforming Growth Factor, beta Receptor 1 (TGFBR1))
    Binding Specificity
    • 9
    • 9
    • 8
    • 8
    • 7
    • 6
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 157-244
    Reactivity
    • 51
    • 49
    • 24
    • 1
    • 1
    Human
    Host
    • 63
    • 3
    • 2
    • 2
    Rabbit
    Clonality
    • 66
    • 4
    Polyclonal
    Conjugate
    • 40
    • 7
    • 5
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This TGFBR1 antibody is un-conjugated
    Application
    • 54
    • 41
    • 20
    • 9
    • 5
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
    Cross-Reactivity
    Human
    Purification
    >95%, Protein G purified
    Immunogen
    Recombinant Human TGF-beta receptor type-1 protein (157-244AA)
    Isotype
    IgG
    Top Product
    Discover our top product TGFBR1 Primary Antibody
  • Application Notes
    Recommended dilution: WB:1:500-1:5000, IHC:1:1000-1:2000, IF:1:200-1:500,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    TGFBR1 (Transforming Growth Factor, beta Receptor 1 (TGFBR1))
    Alternative Name
    TGFBR1 (TGFBR1 Products)
    Synonyms
    AAT5 antibody, ACVRLK4 antibody, ALK-5 antibody, ALK5 antibody, LDS1A antibody, LDS2A antibody, MSSE antibody, SKR4 antibody, TGFR-1 antibody, aat5 antibody, acvrlk4 antibody, alk-5 antibody, alk5 antibody, lds1a antibody, lds2a antibody, skr4 antibody, tgfr-1 antibody, TGFBR1 antibody, x-trr1 antibody, AU017191 antibody, Alk-5 antibody, TbetaR-I antibody, TbetaRI antibody, Alk5 antibody, Skr4 antibody, Tgfr-1 antibody, tbetaR-I antibody, tgfbr1 antibody, zgc:123263 antibody, transforming growth factor beta receptor 1 antibody, transforming growth factor beta receptor I antibody, transforming growth factor beta receptor I S homeolog antibody, transforming growth factor, beta receptor I antibody, transforming growth factor, beta receptor 1 antibody, transforming growth factor, beta receptor 1 a antibody, TGFBR1 antibody, tgfbr1 antibody, tgfbr1.S antibody, Tgfbr1 antibody, tgfbr1a antibody
    Background

    Background: Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 Molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation.

    Aliases: AAT 5 antibody, AAT5 antibody, Activin A receptor type II like kinase 53 kDa antibody, Activin A receptor type II like kinase antibody, Activin A receptor type II like kinase, 53kD antibody, Activin A receptor type II like protein kinase of 53kD antibody, activin A receptor type II-like kinase, 53 kDa antibody, activin A receptor type II-like protein kinase of 53kD antibody, Activin receptor like kinase 5 antibody, Activin receptor-like kinase 5 antibody, ACVRLK 4 antibody, ACVRLK4 antibody, ALK 5 antibody, ALK-5 antibody, ALK5 antibody, LDS1A antibody, LDS2A antibody, MSSE antibody, Serine/threonine protein kinase receptor R4 antibody, Serine/threonine-protein kinase receptor R4 antibody, SKR 4 antibody, SKR4 antibody, TbetaR I antibody, TbetaR-I antibody, TGF beta receptor type 1 antibody, TGF beta receptor type I antibody, TGF beta type I receptor antibody, TGF-beta receptor type I antibody, TGF-beta receptor type-1 antibody, TGF-beta type I receptor antibody, TGFBR 1 antibody, TGFBR1 antibody, TGFBR1 protein antibody, TGFR 1 antibody, TGFR-1 antibody, TGFR1 antibody, TGFR1_HUMAN antibody, Transforming growth factor beta receptor 1 antibody, Transforming growth factor beta receptor I (activin A receptor type II like kinase, 53kD) antibody, Transforming growth factor beta receptor I antibody, transforming growth factor, beta receptor 1 antibody, transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD) antibody, Transforming growth factor-beta receptor type I antibody

    UniProt
    P36897
    Pathways
    Growth Factor Binding
You are here: